nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Tamoxifen—pancreatic cancer	0.613	1	CbGbCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—ABO—pancreatic cancer	0.00661	0.208	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—ACVR1B—pancreatic cancer	0.00577	0.182	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—SHH—pancreatic cancer	0.00273	0.0861	CbGpPWpGaD
Carbimazole—Oropharyngeal discomfort—Docetaxel—pancreatic cancer	0.00268	0.00757	CcSEcCtD
Carbimazole—Liver function test abnormal—Tamoxifen—pancreatic cancer	0.00268	0.00756	CcSEcCtD
Carbimazole—Ageusia—Docetaxel—pancreatic cancer	0.00241	0.00679	CcSEcCtD
Carbimazole—Pancytopenia—Tamoxifen—pancreatic cancer	0.00238	0.00672	CcSEcCtD
Carbimazole—Neutropenia—Tamoxifen—pancreatic cancer	0.00235	0.00662	CcSEcCtD
Carbimazole—Neutropenia—Erlotinib—pancreatic cancer	0.00232	0.00655	CcSEcCtD
Carbimazole—Liver function test abnormal—Sunitinib—pancreatic cancer	0.0023	0.00648	CcSEcCtD
Carbimazole—Stomatitis—Erlotinib—pancreatic cancer	0.00216	0.00609	CcSEcCtD
Carbimazole—Oropharyngeal pain—Docetaxel—pancreatic cancer	0.00215	0.00605	CcSEcCtD
Carbimazole—Pancytopenia—Sunitinib—pancreatic cancer	0.00204	0.00576	CcSEcCtD
Carbimazole—Haemoglobin—Tamoxifen—pancreatic cancer	0.00202	0.00569	CcSEcCtD
Carbimazole—Neutropenia—Sunitinib—pancreatic cancer	0.00201	0.00567	CcSEcCtD
Carbimazole—Hepatitis—Tamoxifen—pancreatic cancer	0.00201	0.00567	CcSEcCtD
Carbimazole—Haemorrhage—Tamoxifen—pancreatic cancer	0.00201	0.00567	CcSEcCtD
Carbimazole—Haemoglobin—Erlotinib—pancreatic cancer	0.002	0.00563	CcSEcCtD
Carbimazole—Haemorrhage—Erlotinib—pancreatic cancer	0.00199	0.00561	CcSEcCtD
Carbimazole—Hepatitis—Erlotinib—pancreatic cancer	0.00199	0.00561	CcSEcCtD
Carbimazole—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00195	0.0055	CcSEcCtD
Carbimazole—Bone marrow depression—Epirubicin—pancreatic cancer	0.00195	0.0055	CcSEcCtD
Carbimazole—Stomatitis—Sunitinib—pancreatic cancer	0.00187	0.00527	CcSEcCtD
Carbimazole—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.00184	0.0052	CcSEcCtD
Carbimazole—Bone marrow depression—Doxorubicin—pancreatic cancer	0.0018	0.00509	CcSEcCtD
Carbimazole—Alopecia—Tamoxifen—pancreatic cancer	0.00178	0.00501	CcSEcCtD
Carbimazole—Alopecia—Erlotinib—pancreatic cancer	0.00176	0.00495	CcSEcCtD
Carbimazole—Haemoglobin—Sunitinib—pancreatic cancer	0.00173	0.00488	CcSEcCtD
Carbimazole—Hepatitis—Sunitinib—pancreatic cancer	0.00172	0.00485	CcSEcCtD
Carbimazole—Haemorrhage—Sunitinib—pancreatic cancer	0.00172	0.00485	CcSEcCtD
Carbimazole—Eosinophilia—Fluorouracil—pancreatic cancer	0.00168	0.00474	CcSEcCtD
Carbimazole—Neutropenia—Irinotecan—pancreatic cancer	0.00166	0.00467	CcSEcCtD
Carbimazole—Pancytopenia—Gemcitabine—pancreatic cancer	0.00164	0.00462	CcSEcCtD
Carbimazole—Ageusia—Epirubicin—pancreatic cancer	0.00162	0.00458	CcSEcCtD
Carbimazole—Neutropenia—Gemcitabine—pancreatic cancer	0.00161	0.00455	CcSEcCtD
Carbimazole—Pancytopenia—Fluorouracil—pancreatic cancer	0.00161	0.00454	CcSEcCtD
Carbimazole—Angioedema—Tamoxifen—pancreatic cancer	0.0016	0.00451	CcSEcCtD
Carbimazole—Leukopenia—Tamoxifen—pancreatic cancer	0.00157	0.00441	CcSEcCtD
Carbimazole—Angiopathy—Sunitinib—pancreatic cancer	0.00156	0.0044	CcSEcCtD
Carbimazole—Stomatitis—Irinotecan—pancreatic cancer	0.00154	0.00434	CcSEcCtD
Carbimazole—Jaundice—Irinotecan—pancreatic cancer	0.00154	0.00434	CcSEcCtD
Carbimazole—Alopecia—Sunitinib—pancreatic cancer	0.00152	0.00429	CcSEcCtD
Carbimazole—Ageusia—Doxorubicin—pancreatic cancer	0.0015	0.00424	CcSEcCtD
Carbimazole—Stomatitis—Gemcitabine—pancreatic cancer	0.0015	0.00423	CcSEcCtD
Carbimazole—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.0015	0.00422	CcSEcCtD
Carbimazole—Arthralgia—Tamoxifen—pancreatic cancer	0.00149	0.0042	CcSEcCtD
Carbimazole—Myalgia—Tamoxifen—pancreatic cancer	0.00149	0.0042	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—pancreatic cancer	0.00148	0.0467	CbGpPWpGaD
Carbimazole—Stomatitis—Fluorouracil—pancreatic cancer	0.00147	0.00416	CcSEcCtD
Carbimazole—Myalgia—Erlotinib—pancreatic cancer	0.00147	0.00415	CcSEcCtD
Carbimazole—Arthralgia—Erlotinib—pancreatic cancer	0.00147	0.00415	CcSEcCtD
Carbimazole—Discomfort—Tamoxifen—pancreatic cancer	0.00147	0.00415	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00146	0.00413	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00145	0.0457	CbGpPWpGaD
Carbimazole—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00144	0.00405	CcSEcCtD
Carbimazole—Haemoglobin—Irinotecan—pancreatic cancer	0.00143	0.00402	CcSEcCtD
Carbimazole—Infection—Tamoxifen—pancreatic cancer	0.00142	0.004	CcSEcCtD
Carbimazole—Haemorrhage—Irinotecan—pancreatic cancer	0.00142	0.004	CcSEcCtD
Carbimazole—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00141	0.00398	CcSEcCtD
Carbimazole—Infection—Erlotinib—pancreatic cancer	0.0014	0.00396	CcSEcCtD
Carbimazole—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.0014	0.00394	CcSEcCtD
Carbimazole—Haemoglobin—Gemcitabine—pancreatic cancer	0.00139	0.00391	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00139	0.00391	CcSEcCtD
Carbimazole—Nervous system disorder—Erlotinib—pancreatic cancer	0.00139	0.00391	CcSEcCtD
Carbimazole—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00138	0.0039	CcSEcCtD
Carbimazole—Haemorrhage—Gemcitabine—pancreatic cancer	0.00138	0.00389	CcSEcCtD
Carbimazole—Skin disorder—Erlotinib—pancreatic cancer	0.00137	0.00387	CcSEcCtD
Carbimazole—Angioedema—Sunitinib—pancreatic cancer	0.00137	0.00386	CcSEcCtD
Carbimazole—Haemoglobin—Fluorouracil—pancreatic cancer	0.00136	0.00385	CcSEcCtD
Carbimazole—Haemorrhage—Fluorouracil—pancreatic cancer	0.00136	0.00383	CcSEcCtD
Carbimazole—Leukopenia—Sunitinib—pancreatic cancer	0.00134	0.00378	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00132	0.0417	CbGpPWpGaD
Carbimazole—Hepatocellular injury—Epirubicin—pancreatic cancer	0.00132	0.00371	CcSEcCtD
Carbimazole—Liver function test abnormal—Docetaxel—pancreatic cancer	0.00131	0.00369	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.0013	0.00367	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00129	0.00363	CcSEcCtD
Carbimazole—Angiopathy—Irinotecan—pancreatic cancer	0.00129	0.00363	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—NOTCH1—pancreatic cancer	0.00128	0.0404	CbGpPWpGaD
Carbimazole—Myalgia—Sunitinib—pancreatic cancer	0.00128	0.0036	CcSEcCtD
Carbimazole—Arthralgia—Sunitinib—pancreatic cancer	0.00128	0.0036	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00127	0.00357	CcSEcCtD
Carbimazole—Angiopathy—Gemcitabine—pancreatic cancer	0.00125	0.00353	CcSEcCtD
Carbimazole—Alopecia—Irinotecan—pancreatic cancer	0.00125	0.00353	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—EGF—pancreatic cancer	0.00124	0.039	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00124	0.00348	CcSEcCtD
Carbimazole—Alopecia—Gemcitabine—pancreatic cancer	0.00122	0.00344	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.00122	0.00343	CcSEcCtD
Carbimazole—Infection—Sunitinib—pancreatic cancer	0.00121	0.00342	CcSEcCtD
Carbimazole—Alopecia—Fluorouracil—pancreatic cancer	0.0012	0.00338	CcSEcCtD
Carbimazole—Nervous system disorder—Sunitinib—pancreatic cancer	0.0012	0.00338	CcSEcCtD
Carbimazole—Thrombocytopenia—Sunitinib—pancreatic cancer	0.0012	0.00338	CcSEcCtD
Carbimazole—Mouth ulceration—Epirubicin—pancreatic cancer	0.00119	0.00336	CcSEcCtD
Carbimazole—Skin disorder—Sunitinib—pancreatic cancer	0.00119	0.00335	CcSEcCtD
Carbimazole—Pancytopenia—Docetaxel—pancreatic cancer	0.00116	0.00328	CcSEcCtD
Carbimazole—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00115	0.00323	CcSEcCtD
Carbimazole—Neutropenia—Docetaxel—pancreatic cancer	0.00115	0.00323	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00114	0.00322	CcSEcCtD
Carbimazole—Urticaria—Tamoxifen—pancreatic cancer	0.00113	0.0032	CcSEcCtD
Carbimazole—Body temperature increased—Erlotinib—pancreatic cancer	0.00112	0.00315	CcSEcCtD
Carbimazole—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00112	0.00314	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00111	0.00314	CcSEcCtD
Carbimazole—Malaise—Irinotecan—pancreatic cancer	0.00111	0.00314	CcSEcCtD
Carbimazole—Leukopenia—Irinotecan—pancreatic cancer	0.0011	0.00311	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—pancreatic cancer	0.0011	0.0031	CcSEcCtD
Carbimazole—Malaise—Gemcitabine—pancreatic cancer	0.00108	0.00306	CcSEcCtD
Carbimazole—Leukopenia—Gemcitabine—pancreatic cancer	0.00108	0.00303	CcSEcCtD
Carbimazole—Stomatitis—Docetaxel—pancreatic cancer	0.00106	0.003	CcSEcCtD
Carbimazole—Jaundice—Docetaxel—pancreatic cancer	0.00106	0.003	CcSEcCtD
Carbimazole—Leukopenia—Fluorouracil—pancreatic cancer	0.00106	0.00298	CcSEcCtD
Carbimazole—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00105	0.00297	CcSEcCtD
Carbimazole—Discomfort—Irinotecan—pancreatic cancer	0.00104	0.00293	CcSEcCtD
Carbimazole—Myalgia—Gemcitabine—pancreatic cancer	0.00102	0.00289	CcSEcCtD
Carbimazole—Arthralgia—Gemcitabine—pancreatic cancer	0.00102	0.00289	CcSEcCtD
Carbimazole—Agranulocytosis—Docetaxel—pancreatic cancer	0.00102	0.00287	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00102	0.00287	CcSEcCtD
Carbimazole—Discomfort—Gemcitabine—pancreatic cancer	0.00101	0.00285	CcSEcCtD
Carbimazole—Pruritus—Tamoxifen—pancreatic cancer	0.00101	0.00285	CcSEcCtD
Carbimazole—Myalgia—Fluorouracil—pancreatic cancer	0.00101	0.00284	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.001	0.0316	CbGpPWpGaD
Carbimazole—Infection—Irinotecan—pancreatic cancer	0.001	0.00282	CcSEcCtD
Carbimazole—Pruritus—Erlotinib—pancreatic cancer	0.000999	0.00282	CcSEcCtD
Carbimazole—Discomfort—Fluorouracil—pancreatic cancer	0.000994	0.0028	CcSEcCtD
Carbimazole—Nervous system disorder—Irinotecan—pancreatic cancer	0.000988	0.00278	CcSEcCtD
Carbimazole—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000986	0.00278	CcSEcCtD
Carbimazole—Haemoglobin—Docetaxel—pancreatic cancer	0.000985	0.00278	CcSEcCtD
Carbimazole—Haemorrhage—Docetaxel—pancreatic cancer	0.00098	0.00276	CcSEcCtD
Carbimazole—Hepatitis—Docetaxel—pancreatic cancer	0.00098	0.00276	CcSEcCtD
Carbimazole—Infection—Gemcitabine—pancreatic cancer	0.000975	0.00275	CcSEcCtD
Carbimazole—Body temperature increased—Sunitinib—pancreatic cancer	0.000967	0.00273	CcSEcCtD
Carbimazole—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000962	0.00271	CcSEcCtD
Carbimazole—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000961	0.00271	CcSEcCtD
Carbimazole—Infection—Fluorouracil—pancreatic cancer	0.000958	0.0027	CcSEcCtD
Carbimazole—Skin disorder—Gemcitabine—pancreatic cancer	0.000953	0.00269	CcSEcCtD
Carbimazole—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000946	0.00267	CcSEcCtD
Carbimazole—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000945	0.00266	CcSEcCtD
Carbimazole—Hypersensitivity—Sunitinib—pancreatic cancer	0.000901	0.00254	CcSEcCtD
Carbimazole—Rash—Tamoxifen—pancreatic cancer	0.0009	0.00254	CcSEcCtD
Carbimazole—Dermatitis—Tamoxifen—pancreatic cancer	0.000899	0.00254	CcSEcCtD
Carbimazole—Headache—Tamoxifen—pancreatic cancer	0.000894	0.00252	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000894	0.00252	CcSEcCtD
Carbimazole—Rash—Erlotinib—pancreatic cancer	0.000891	0.00251	CcSEcCtD
Carbimazole—Dermatitis—Erlotinib—pancreatic cancer	0.00089	0.00251	CcSEcCtD
Carbimazole—Angiopathy—Docetaxel—pancreatic cancer	0.000889	0.00251	CcSEcCtD
Carbimazole—Headache—Erlotinib—pancreatic cancer	0.000885	0.00249	CcSEcCtD
Carbimazole—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000882	0.00249	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000879	0.00248	CcSEcCtD
Carbimazole—Alopecia—Docetaxel—pancreatic cancer	0.000866	0.00244	CcSEcCtD
Carbimazole—Pruritus—Sunitinib—pancreatic cancer	0.000865	0.00244	CcSEcCtD
Carbimazole—Nausea—Tamoxifen—pancreatic cancer	0.000848	0.00239	CcSEcCtD
Carbimazole—Nausea—Erlotinib—pancreatic cancer	0.000839	0.00237	CcSEcCtD
Carbimazole—Feeling abnormal—Irinotecan—pancreatic cancer	0.00083	0.00234	CcSEcCtD
Carbimazole—Eosinophilia—Epirubicin—pancreatic cancer	0.000818	0.00231	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000816	0.0023	CcSEcCtD
Carbimazole—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000809	0.00228	CcSEcCtD
Carbimazole—Body temperature increased—Irinotecan—pancreatic cancer	0.000796	0.00224	CcSEcCtD
Carbimazole—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000795	0.00224	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—pancreatic cancer	0.000784	0.00221	CcSEcCtD
Carbimazole—Body temperature increased—Gemcitabine—pancreatic cancer	0.000776	0.00219	CcSEcCtD
Carbimazole—Neutropenia—Epirubicin—pancreatic cancer	0.000772	0.00218	CcSEcCtD
Carbimazole—Rash—Sunitinib—pancreatic cancer	0.000771	0.00217	CcSEcCtD
Carbimazole—Dermatitis—Sunitinib—pancreatic cancer	0.00077	0.00217	CcSEcCtD
Carbimazole—Urticaria—Fluorouracil—pancreatic cancer	0.000766	0.00216	CcSEcCtD
Carbimazole—Headache—Sunitinib—pancreatic cancer	0.000766	0.00216	CcSEcCtD
Carbimazole—Leukopenia—Docetaxel—pancreatic cancer	0.000764	0.00215	CcSEcCtD
Carbimazole—Body temperature increased—Fluorouracil—pancreatic cancer	0.000763	0.00215	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—pancreatic cancer	0.000757	0.00213	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—VEGFA—pancreatic cancer	0.00075	0.0236	CbGpPWpGaD
Carbimazole—Hypersensitivity—Irinotecan—pancreatic cancer	0.000742	0.00209	CcSEcCtD
Carbimazole—Arthralgia—Docetaxel—pancreatic cancer	0.000726	0.00205	CcSEcCtD
Carbimazole—Myalgia—Docetaxel—pancreatic cancer	0.000726	0.00205	CcSEcCtD
Carbimazole—Nausea—Sunitinib—pancreatic cancer	0.000726	0.00205	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—pancreatic cancer	0.000726	0.00205	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000721	0.00203	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—pancreatic cancer	0.000718	0.00202	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—pancreatic cancer	0.000718	0.00202	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—pancreatic cancer	0.000715	0.00201	CcSEcCtD
Carbimazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000711	0.002	CcSEcCtD
Carbimazole—Pruritus—Gemcitabine—pancreatic cancer	0.000694	0.00196	CcSEcCtD
Carbimazole—Infection—Docetaxel—pancreatic cancer	0.000692	0.00195	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—TGFB1—pancreatic cancer	0.000689	0.0217	CbGpPWpGaD
Carbimazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000687	0.00194	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—TSC2—pancreatic cancer	0.000686	0.0216	CbGpPWpGaD
Carbimazole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000683	0.00193	CcSEcCtD
Carbimazole—Pruritus—Fluorouracil—pancreatic cancer	0.000683	0.00192	CcSEcCtD
Carbimazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000682	0.00192	CcSEcCtD
Carbimazole—Skin disorder—Docetaxel—pancreatic cancer	0.000676	0.00191	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—pancreatic cancer	0.000664	0.00187	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—pancreatic cancer	0.000664	0.00187	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—pancreatic cancer	0.000664	0.00187	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—pancreatic cancer	0.000661	0.00186	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—pancreatic cancer	0.000661	0.00186	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000636	0.00179	CcSEcCtD
Carbimazole—Rash—Irinotecan—pancreatic cancer	0.000635	0.00179	CcSEcCtD
Carbimazole—Dermatitis—Irinotecan—pancreatic cancer	0.000635	0.00179	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000634	0.00179	CcSEcCtD
Carbimazole—Headache—Irinotecan—pancreatic cancer	0.000631	0.00178	CcSEcCtD
Carbimazole—Rash—Gemcitabine—pancreatic cancer	0.000619	0.00174	CcSEcCtD
Carbimazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000618	0.00174	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—pancreatic cancer	0.000615	0.00173	CcSEcCtD
Carbimazole—Headache—Gemcitabine—pancreatic cancer	0.000615	0.00173	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000612	0.00172	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—pancreatic cancer	0.000612	0.00172	CcSEcCtD
Carbimazole—Rash—Fluorouracil—pancreatic cancer	0.000608	0.00171	CcSEcCtD
Carbimazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000608	0.00171	CcSEcCtD
Carbimazole—Headache—Fluorouracil—pancreatic cancer	0.000604	0.0017	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—pancreatic cancer	0.0006	0.00169	CcSEcCtD
Carbimazole—Nausea—Irinotecan—pancreatic cancer	0.000598	0.00169	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—pancreatic cancer	0.000584	0.00165	CcSEcCtD
Carbimazole—Nausea—Gemcitabine—pancreatic cancer	0.000583	0.00164	CcSEcCtD
Carbimazole—Feeling abnormal—Docetaxel—pancreatic cancer	0.000574	0.00162	CcSEcCtD
Carbimazole—Nausea—Fluorouracil—pancreatic cancer	0.000573	0.00162	CcSEcCtD
Carbimazole—Angiopathy—Doxorubicin—pancreatic cancer	0.000555	0.00156	CcSEcCtD
Carbimazole—Body temperature increased—Docetaxel—pancreatic cancer	0.00055	0.00155	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—pancreatic cancer	0.000541	0.00152	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000534	0.00151	CcSEcCtD
Carbimazole—Malaise—Epirubicin—pancreatic cancer	0.000519	0.00146	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—pancreatic cancer	0.000515	0.00145	CcSEcCtD
Carbimazole—Hypersensitivity—Docetaxel—pancreatic cancer	0.000513	0.00145	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000494	0.00139	CcSEcCtD
Carbimazole—Pruritus—Docetaxel—pancreatic cancer	0.000493	0.00139	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—pancreatic cancer	0.00049	0.00138	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—pancreatic cancer	0.00049	0.00138	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000487	0.00137	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—pancreatic cancer	0.000484	0.00136	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—pancreatic cancer	0.00048	0.00135	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—pancreatic cancer	0.000477	0.00134	CcSEcCtD
Carbimazole—Infection—Epirubicin—pancreatic cancer	0.000467	0.00132	CcSEcCtD
Carbimazole—Nervous system disorder—Epirubicin—pancreatic cancer	0.000461	0.0013	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00046	0.0013	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—pancreatic cancer	0.000456	0.00129	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—pancreatic cancer	0.000453	0.00128	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—pancreatic cancer	0.000453	0.00128	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00045	0.00127	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—pancreatic cancer	0.000448	0.00126	CcSEcCtD
Carbimazole—Rash—Docetaxel—pancreatic cancer	0.000439	0.00124	CcSEcCtD
Carbimazole—Dermatitis—Docetaxel—pancreatic cancer	0.000439	0.00124	CcSEcCtD
Carbimazole—Headache—Docetaxel—pancreatic cancer	0.000436	0.00123	CcSEcCtD
Carbimazole—Infection—Doxorubicin—pancreatic cancer	0.000432	0.00122	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000428	0.00121	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000426	0.0012	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000426	0.0012	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—pancreatic cancer	0.000422	0.00119	CcSEcCtD
Carbimazole—Nausea—Docetaxel—pancreatic cancer	0.000414	0.00117	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000396	0.00112	CcSEcCtD
Carbimazole—Feeling abnormal—Epirubicin—pancreatic cancer	0.000387	0.00109	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000381	0.012	CbGpPWpGaD
Carbimazole—Urticaria—Epirubicin—pancreatic cancer	0.000373	0.00105	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—SRC—pancreatic cancer	0.000372	0.0117	CbGpPWpGaD
Carbimazole—Body temperature increased—Epirubicin—pancreatic cancer	0.000371	0.00105	CcSEcCtD
Carbimazole—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000358	0.00101	CcSEcCtD
Carbimazole—Hypersensitivity—Epirubicin—pancreatic cancer	0.000346	0.000976	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—pancreatic cancer	0.000345	0.000973	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—pancreatic cancer	0.000344	0.000968	CcSEcCtD
Carbimazole—Pruritus—Epirubicin—pancreatic cancer	0.000332	0.000937	CcSEcCtD
Carbimazole—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00032	0.000903	CcSEcCtD
Carbimazole—Pruritus—Doxorubicin—pancreatic cancer	0.000307	0.000867	CcSEcCtD
Carbimazole—TPO—Metabolism—PRSS1—pancreatic cancer	0.000307	0.00968	CbGpPWpGaD
Carbimazole—Rash—Epirubicin—pancreatic cancer	0.000296	0.000835	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—pancreatic cancer	0.000296	0.000834	CcSEcCtD
Carbimazole—Headache—Epirubicin—pancreatic cancer	0.000294	0.000829	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.000283	0.0089	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—pancreatic cancer	0.000279	0.000786	CcSEcCtD
Carbimazole—Rash—Doxorubicin—pancreatic cancer	0.000274	0.000772	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—pancreatic cancer	0.000274	0.000772	CcSEcCtD
Carbimazole—Headache—Doxorubicin—pancreatic cancer	0.000272	0.000767	CcSEcCtD
Carbimazole—TPO—Metabolism—ARG2—pancreatic cancer	0.000267	0.00839	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—pancreatic cancer	0.000258	0.000728	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.000242	0.00762	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TYMP—pancreatic cancer	0.000233	0.00734	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—pancreatic cancer	0.000231	0.00728	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.000219	0.00689	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000212	0.00668	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GLP1R—pancreatic cancer	0.000188	0.00591	CbGpPWpGaD
Carbimazole—TPO—Metabolism—DPYD—pancreatic cancer	0.000185	0.00582	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC2A2—pancreatic cancer	0.000175	0.00552	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000173	0.00545	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000141	0.00444	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000141	0.00443	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CD44—pancreatic cancer	0.000136	0.00427	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GCG—pancreatic cancer	0.00013	0.0041	CbGpPWpGaD
Carbimazole—TPO—Metabolism—STK11—pancreatic cancer	0.000122	0.00385	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000108	0.00339	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TYMS—pancreatic cancer	0.000105	0.00331	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000105	0.0033	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000104	0.00327	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000101	0.00319	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PRSS1—pancreatic cancer	9.37e-05	0.00295	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	9.14e-05	0.00288	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—pancreatic cancer	8.56e-05	0.0027	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	8.41e-05	0.00265	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	8.23e-05	0.00259	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ARG2—pancreatic cancer	8.12e-05	0.00256	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	7.77e-05	0.00245	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—pancreatic cancer	7.73e-05	0.00243	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARG—pancreatic cancer	7.46e-05	0.00235	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TYMP—pancreatic cancer	7.1e-05	0.00224	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	6.91e-05	0.00217	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—pancreatic cancer	6.79e-05	0.00214	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—pancreatic cancer	5.92e-05	0.00186	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—pancreatic cancer	5.87e-05	0.00185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.86e-05	0.00184	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	5.83e-05	0.00184	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GLP1R—pancreatic cancer	5.72e-05	0.0018	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—DPYD—pancreatic cancer	5.63e-05	0.00177	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	5.34e-05	0.00168	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.29e-05	0.00167	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—pancreatic cancer	5.12e-05	0.00161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.1e-05	0.00161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.65e-05	0.00146	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CD44—pancreatic cancer	4.14e-05	0.0013	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.05e-05	0.00128	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.02e-05	0.00126	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCG—pancreatic cancer	3.97e-05	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STK11—pancreatic cancer	3.73e-05	0.00117	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—pancreatic cancer	3.61e-05	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.5e-05	0.0011	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TYMS—pancreatic cancer	3.21e-05	0.00101	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—pancreatic cancer	2.95e-05	0.000928	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—pancreatic cancer	2.61e-05	0.000822	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.47e-05	0.000778	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	2.36e-05	0.000742	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—pancreatic cancer	2.27e-05	0.000716	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	2.07e-05	0.000652	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	1.8e-05	0.000568	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—pancreatic cancer	1.79e-05	0.000563	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—pancreatic cancer	1.56e-05	0.000491	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	1.1e-05	0.000346	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—pancreatic cancer	8.99e-06	0.000283	CbGpPWpGaD
